Temasek Holdings’s Zimmer Biomet ZBH Stock Holding History

Temasek Holdings’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-65,596	Closed	-$9.81M	–	78
2020 Q4	$9.81M	Buy	+65,596	New	+$9.26M	0.04%	62

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Temasek Holdings's ZBH Position: Q1 2021 in Review

Temasek Holdings sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 65,596 shares — an estimated $9.81M sold.

Temasek Holdings first reported a position in ZBH in Q4 2020 and held it in 1 quarter. The position peaked at $9.81M in Q4 2020. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

Temasek Holdings reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
Temasek Holdings sold 65,596 Zimmer Biomet shares in Q1 2021, an estimated $9.81M.
Temasek Holdings first reported a position in Zimmer Biomet in Q4 2020 and held it in 1 quarter.
Temasek Holdings's Zimmer Biomet position peaked at $9.81M in Q4 2020.
1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Temasek Holdings's 13F filing for Q1 2021, filed 17 May 2021.